In this article, we will take a look at the 10 Best Blue Chip Stocks to Buy for 2026.
Blue-chip stocks are set to dominate the pace and direction of the US equity market. That’s the sentiment echoed by Wall Street strategists as the economy remains resilient amid monetary policy easing. Goldman Sachs’ Tony Pasquariello expects sustained momentum from these market leaders amid the artificial intelligence boom.
The Dow Jones Industrial Average has already powered to all-time high at the start of the new trading year, affirming strong investor sentiment in the largest blue-chip companies. Likewise, the broadened rally is moving beyond the narrow confines of mega-cap technology companies into the industrial, financial, and biotechnology sectors.
Interest rate cuts are one of the factors supporting the mega cap stock outlook, helping sustain upward momentum despite the premium valuations. Federal Reserve Chairman Jerome Powell, hinting at a “shallow but steady” path of rate cuts, has given equity strategists the green light to raise price targets for blue-chip stocks.
US Treasury Secretary Scott Bessent has already reiterated that lower interest rates are the missing piece needed to accelerate economic growth.
“Cutting interest rates will have a tangible impact on the lives of every Minnesotan,” he said, according to excerpts obtained from a source in the administration. “It is the only ingredient missing for even stronger economic growth. Which is why the Fed should not delay.”
Likewise, Goldman Sachs expects a cyclical upturn in the economy to provide a favorable macroeconomic backdrop for large-cap stocks. The investment bank expects mega-cap tech stocks to drive nearly half of S&P 500 earnings growth. Morgan Stanley expects mid-teens earnings growth and deregulation to drive the markets higher.

Our Methodology
We sifted through blue-chip ETFs and compiled a list of key holdings across sectors. From that list, we identified stocks with upside potential of more than 20% as of January 15. Additionally, we have mentioned the number of hedge funds that hold stakes in them, as of Q3 2025. Finally, we have ranked the stocks in ascending order based on their upside potential.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
Best Blue Chip Stocks to Buy for 2026
10. BlackRock, Inc. (NYSE:BLK)
Upside Potential: 21.01%
Number of Hedge Fund Holders: 63
BlackRock Inc. (NYSE:BLK) is one of the best blue-chip stocks to buy for 2026. On January 6, reports emerged indicating BlackRock Inc. (NYSE:BLK) is seeking regulatory clearance in India to acquire an unspecified stake in Mumbai-based renewable platform Aditya Birla Renewables Limited.
The asset management firm has committed to invest $333.6 million in the renewable energy company, which is active in solar, wind, solar-plus-wind, and battery storage. It owns a portfolio of 4.3GW across 10 Indian states. The investment comes at a time when India is undergoing one of the most significant energy transformations. There is a growing demand for renewable energy driven by the need for decarbonization and rising demand. Likewise, on January 6, BlackRock confirmed a 6.72% stake in Ireland’s Avadel Pharmaceuticals. The investment further strengthens the asset management firm’s exposure in the healthcare sector.
Meanwhile, Morgan Stanley reiterated an Overweight rating on BlackRock and set a $1,514 price target. The positive stance comes from the company expanding its offerings in private markets and technology solutions through its Aladdin platform.
BlackRock, Inc. (NYSE:BLK) is the world’s largest asset manager, providing investment management and financial technology services to help individuals and institutions grow their wealth. They manage trillions of dollars in assets, investing clients’ money in stocks, bonds, ETFs (including their popular iShares brand), real estate, and more, and offering retirement solutions.
9. Amazon.com, Inc. (NASDAQ:AMZN)
Upside Potential: 21.47%
Number of Hedge Fund Holders: 332
Amazon.com Inc (NASDAQ:AMZN) is one of the best blue-chip stocks to buy for 2026. On January 5, analysts at Evercore ISI reiterated an outperform rating on Amazon.com Inc (NASDAQ:AMZN) and set a $335 price target. According to the research firm, the e-commerce giant is well-positioned for growth driven by its AI-powered shopping assistant, Rufus.
Evercore ISI expects Rufus and other AI commerce features to bolster Amazon’s retail gross merchandise volume by 4.44% by 2028. Last year alone, more than 250 million customers used the generative AI-powered conversational shopping assistant. Increased use led to a $10 billion increase in gross merchandise volume.
Rufus Edge stems from the fact that 60% of customers who use it often complete a purchase, thereby strengthening the company’s gross merchandise volume. Its use is expected to increase with the rollout of additional AI features, including AutoBuy and Predicting Bundling. Additionally, Evercore ISI expects Rufus to enhance Amazon’s ad revenue by about $4 billion by 2028. The increase would come as AI shopping helps guide and extract greater intent.
Meanwhile, on January 7, Amazon’s cloud unit entered into a strategic partnership with Infosys to develop more enterprise services using generative artificial intelligence. The partnership will result in the integration of Topaz AI services with Amazon Web Services AI assistant to offer comprehensive gen AI services to companies.
Amazon.com, Inc. (NASDAQ:AMZN) is a global tech giant known primarily for its massive e-commerce platform, which sells a vast selection of goods directly and allows millions of third-party sellers to use its marketplace. It’s also a leading provider of cloud computing services, offering scalable infrastructure, databases, AI, and more to businesses.
8. CVS Health Corporation (NYSE:CVS)
Upside Potential: 21.91%
Number of Hedge Fund Holders: 78
CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy for 2026. On January 6, CVS Health Corporation (NYSE:CVS)’s board approved a quarterly dividend of $0.665 a share. The dividend is to be paid on February 2, 2026, to shareholders of record as of January 22. It marks the 55th consecutive year that the company has rewarded investors with dividends, with the stock currently yielding 3.31%.
The dividend offering coincides with Cantor Fitzgerald reiterating CVS Health as its preferred stock for Medicare Advantage exposure this year. According to the research firm, the company remains well-positioned to benefit from a favorable regulatory environment.
Likewise, Bernstein raised its price target for the stock to $87 from $86 while reiterating a Market Perform rating. The price target hike is in response to the research firm’s touting of the successful execution of a turnaround strategy. The research firm also views Aetna as an attractive growth engine expected to drive future performance despite headwinds in the pharmacy benefit environment. Bernstein expects CVS to benefit from growth in pharmacy benefit managers alongside an increase in drug spend.
CVS Health Corporation (NYSE:CVS) is a major U.S. healthcare company that integrates retail pharmacies (CVS Pharmacy), health insurance (Aetna), and pharmacy benefits management (CVS Caremark) to provide a connected health experience, offering everything from prescriptions and wellness products to insurance plans.
7. Meta Platforms, Inc. (NASDAQ:META)
Upside Potential: 30.72%
Number of Hedge Fund Holders: 273
Meta Platforms Inc. (NASDAQ:META) is one of the best blue-chip stocks to buy for 2026. On January 9, CNBC reported that Meta Platforms Inc. (NASDAQ:META) has signed nuclear energy deals with Vistra, TerraPower, and Oklo. The deals are part of the company’s bid to secure clean energy to power its Prometheus supercluster as it seeks to develop superintelligence.
Prometheus is one of the company’s advanced artificial intelligence efforts spanning multiple data center buildings. The deals are expected to support 6.6 gigawatts of new and existing clean energy by 2035. An agreement with Terra Power is likely to result in the development of two new Natrium units capable of generating 690 megawatts.
Meta will also buy more than 2.1 gigawatts of energy from Vistra nuclear plants in Ohio. A deal with Oklo will result in the development of 1.2 gigawatts of power to support Meta’s data centers.
Meanwhile, on January 12, BofA Securities reiterated a Buy rating and an $810 price target on Meta Platforms following confirmation of the nuclear energy deals. The research firm expects the deals to address power availability constraints for data center expansion. The company is also likely to secure capacity and pricing certainty for its AI infrastructure growth.
Meta Platforms, Inc. (NASDAQ:META) is a technology company that offers solutions to connect people through social media (Facebook, Instagram, WhatsApp, Messenger, Threads). It’s also heavily investing in the “metaverse” with virtual and mixed-reality hardware (like Meta Quest) and software, while using targeted advertising for revenue.
6. Boston Scientific Corporation (NYSE:BSX)
Upside Potential: 31.69%
Number of Hedge Fund Holders: 102
Boston Scientific Corporation (NYSE:BSX) is one of the best blue-chip stocks to buy for 2026. Boston Scientific Corporation (NYSE:BSX) said on January 12 that it has agreed to acquire Valencia Technologies, maker of the FDA-approved eCoin System for urge urinary incontinence. The coin-sized implant, placed near the ankle, uses tibial nerve stimulation to help control bladder activity and showed a 68% response rate in clinical trials. The acquisition expands Boston Scientific’s urology and pelvic health portfolio with implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with no disclosed financial terms and minimal impact on adjusted earnings.
On January 6, JPMorgan reiterated Boston Scientific Corporation (NYSE:BSX) is one of its top pick stocks in the healthcare sector. According to the investment bank, the company is well-positioned in the medical device market.
Backed by cardiovascular, rhythm management, and endoscopy product lines, Boston Scientific has etched its name as a leader in minimally invasive medical technologies. That was the catalyst behind the company delivering third-quarter revenue that was above analyst expectations.
Likewise, UBS reiterated a Buy rating on the stock on December 17 and set a $140 price target. According to analyst Danielle Antalffy, the stock’s risk-reward profile is skewed to the upside given the high-growth businesses in play. Chief Executive Officer Mike Mahoney has already reiterated plans to grow the Electrophysiology (EP) division, which accounts for 17% of sales, to 20-25%.
UBS expects the medical devices company to guide 2026 sales growth above its long-range plan of 10% to 12%. Most of the growth would be driven by strong momentum in the WATCHMAN business.
Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets a wide range of innovative medical devices and solutions used by healthcare professionals worldwide to diagnose and treat complex conditions in areas such as cardiology, endoscopy, oncology, urology, and neuromodulation, with a focus on improving patient outcomes and advancing less-invasive medicine.
5. Uber Technologies Inc. (NYSE:UBER)
Upside Potential: 33.39%
Number of Hedge Fund Holders: 143
Uber Technologies Inc. (NYSE:UBER) is one of the best blue-chip stocks to buy for 2026. On January 6, BofA Securities reiterated a Buy rating on Uber Technologies Inc. (NYSE:UBER) and set a $119 price target. The research firm has echoed the company’s positioning in the autonomous vehicle market, which is critical to its long-term prospects.
According to BofA Securities, a strategic partnership with Nvidia positions Uber to accelerate the adoption of Level 4 autonomous technology. It expects Nvidia’s hardware and software solutions to lower barriers to entry for original equipment manufacturers, thereby benefiting the sector. Consequently, Uber would be well-positioned to purchase and lease autonomous vehicles for its network.
BofA Securities also expects increased competition among autonomous vehicle manufacturers to result in more autonomous vehicles on Uber’s network. More AV on Uber networks asserts the research firm’s bullish stance on the stock.
Likewise, analysts at Bernstein SocGen have also reiterated a positive stance on Uber stock, maintaining an outperform rating and a $115 price target. The stance comes amid soaring competition in the AV market.
Uber Technologies Inc. (NYSE:UBER) is a global tech company that operates a multi-sided platform connecting users with transportation, food delivery, and freight services. It offers logistics solutions, with its core segments being Mobility, Delivery, and Freight.
4. Microsoft Corporation (NASDAQ:MSFT)
Upside Potential: 34.14%
Number of Hedge Fund Holders: 312
Microsoft Corporation (NASDAQ:MSFT) is one of the best blue-chip stocks to buy for 2026. On January 7, CNBC reported that Microsoft Corporation (NASDAQ:MSFT) is the company behind a controversial data center in Michigan. Lowell Township residents have opposed the proposed data center, even as it is expected to result in an investment of between $500 million and $1 billion over the next three to five years.
A bone of contention is the growing concern that the proposed data center will draw as much electricity as an entire city and use significant amounts of water. There are also concerns that the data center will affect field trips to the Heidi Farmstand and Bakery. The objection comes as Microsoft explores doubling the size of its data centers over the next two years to capitalize on the AI boom.
Meanwhile, on January 5, Jefferies reiterated a Buy rating and a $675 price target on Microsoft Corporation (NASDAQ:MSFT). The positive stance is in response to the company showing strength across its businesses, including cloud computing, productivity software, and personal computing. Microsoft is increasingly expanding its artificial intelligence capabilities by integrating AI features in its product portfolio.
Microsoft Corporation (NASDAQ:MSFT) is a global technology leader offering software, cloud solutions, devices, and gaming products designed to help individuals and organizations achieve more.
3. Broadcom Inc. (NASDAQ:AVGO)
Upside Potential: 35.31%
Number of Hedge Fund Holders: 183
Broadcom Inc. (NASDAQ:AVGO) is one of the best blue-chip stocks to buy for 2026. On January 6, Broadcom Inc. (NASDAQ:AVGO) expanded its Wi-Fi 8 portfolio with the launch of BCM4918, an accelerated processing unit and dual-band Wi-Fi 8 devices, the BCM6714 and BCM6719.
The new chipsets are designed to support artificial intelligence-driven applications and also offer improved security and power efficiency. Backed by higher throughput plus smart intelligence, the unified Wi-Fi 8 platform will deliver real-time agentic applications for residential consumers. The platform will also combine compute acceleration, advanced networking, and robust security to provide high throughput and low latency in AI-driven connected ecosystems.
“Our new BCM4918 APU, along with our full portfolio of Wi-Fi 8 chipsets, form the foundation of an AI-ready platform that not only enables immersive, intelligent user experiences but also does so with efficiency, security, and sustainability at its core,” said Mark Gonikberg, senior vice president and general manager of Broadcom’s Wireless and Broadband Communications Division.
Meanwhile, UBS hiked its price target of the stock to $475 from $472 while reiterating a Buy rating. The positive stance underscores the research firm’s confidence about the company’s AI semiconductor revenue for 2026, expected to exceed $60 billion.
Broadcom Inc. (NASDAQ:AVGO) is a semiconductor company that designs and supplies a vast range of semiconductor chips and infrastructure software for critical technology markets, connecting everything from data centers and cloud infrastructure to broadband, wireless, storage, and enterprise systems.
2. NVIDIA Corporation (NASDAQ:NVDA)
Upside Potential: 43.47%
Number of Hedge Fund Holders: 234
NVIDIA Corporation (NASDAQ:NVDA) is one of the best blue-chip stocks to buy for 2026. On January 6, Piper Sandler reiterated an Overweight rating and a $225 price target for NVIDIA Corporation (NASDAQ:NVDA). The positive stance follows the company’s CES presentation, which underscored its technological positioning.
Reuters reported on January 6 that the company’s next-generation chips are in full production, as the Chief Executive Officer reiterated that they can deliver 5 times the artificial intelligence computing power of previous chips.
The company’s Vera Rubin AI platform, tailored for data centers, has already entered production, with the first devices slated for release in the second half of 2026. The platform is poised to offer a new revenue stream. In addition, the company is also ramping up production of Blackwell and hopper generation chips, expected to strengthen the impressive 65.22% revenue growth.
Likewise, on January 6, the company entered into a strategic partnership with Siemens to develop artificial intelligence solutions for industrial applications. The two plan to develop an AI-accelerated portfolio that spans design, simulation, manufacturing, and supply chains. Part of the plan also entails creating an Industrial AI operating system that redefines how physical systems are designed and operated.
NVIDIA Corporation (NASDAQ:NVDA) designs and manufactures Graphics Processing Units (GPUs) and other chips, evolving from a gaming hardware leader into the backbone of modern Artificial Intelligence (AI) infrastructure, powering data centers, self-driving cars, scientific research, and professional visualization through its accelerated computing platforms and software such as CUDA.
1. Sanofi (NASDAQ:SNY)
Upside Potential: 64.98%
Number of Hedge Fund Holders: 32
Sanofi (NASDAQ:SNY) is one of the best blue-chip stocks to buy for 2026. On January 5, the US Food and Drug Administration announced the approval of Sanofi SA (NASDAQ:SNY)’s Cablivi. The approval covers the use of the injection to treat pediatric patients 12 years of age and older with acquired thrombotic thrombocytopenic purpura (aTTP).
The injection was first approved in 2019 for the treatment of adults with thrombotic thrombocytopenic purpura (aTTP). It stands out in its ability to target rare blood disorders that affect 1 to 10 million children annually. It was approved after studies showed that 80% of patients achieved clinical remission, defined as a normal platelet count.
Following Cablivi approval in the US, Sanofi has been given the green light to launch plozasiran in China. China’s National Medical Products Administration (NMPA) has approved plozasiran) for reducing triglyceride levels in adult patients with familial chylomicronemia syndrome (FCS). The company acquired rights to the drug from Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)’s subsidiary, Visirna, and is poised to pay a $10 million milestone payment.
Plozasiran approval in China follows approvals in the US and Canada, while it is under review in various jurisdictions worldwide.
On December 28, Jefferies maintained its Buy rating on Sanofi (NASDAQ:SNY) with a €100 price target. The firm acknowledged investor unease following the FDA’s Complete Response Letter for tolebrutinib, noting it raises “tough questions about management communication” and may weigh on market sentiment.
Sanofi (NASDAQ:SNY) is a global French healthcare company that researches, develops, manufactures, and markets a broad range of pharmaceutical products, including prescription medicines, vaccines, and over-the-counter (OTC) consumer healthcare products.
While we acknowledge the potential of Sanofi (NASDAQ:SNY) to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SNY and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Penny Stocks to Buy for 2026 and 10 Best Metal Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.





